Release date: 3 May 2006
Promoter – Financial Intermediary
Chiesi Farmaceutici SpA is the holding company of a medium-sized privately owned pharmaceutical group based in Parma. The promoter is dedicated to the research, development and commercialisation of products in four core therapeutic areas: respiratory, cardiovascular, musculo-skeletal inflammation and neonatology.Location
Description
The present project represents the first operation with Chiesi Farmaceutici and is aimed at assisting the construction of a new R&D centre as well as the upgrade of the equipment, allowing the rationalization of Chiesi's R&D activities and their future development.
Objectives
Chiesi is one of the leading pharmaceutical companies in Italy. Although being a mid-sized privately owned group, Chiesi invests every year a significant portion of total turnover (13% in 2004) in R&D. The investments will strengthen the regional and local endowment of R&D and contribute to the EU's private sector investments in R&D, in line with the Bank's i2i plan concerning the promotion and strengthening of scientific research.
Comments
Research & Development
Sector(s)
Proposed EIB finance (Approximate amount)
EUR 30 million
Total cost (Approximate amount)
EUR 60 million
Environmental aspects
To be verified during appraisal.
Procurement
To be verified during appraisal.
Status
Signed - 3/04/2009
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).